Optavia News

Optavia Parent Reports Second Quarter Revenue of 76.4 Million Dollars

Press Release | 8/3/2026

BALTIMORE, Md. -- August 3, 2026

Medifast reported second-quarter 2026 revenue of 76.4 million dollars for its Optavia business, with revenue per active earning coach of 6,529 dollars and 11,700 independent active earning coaches.

Net loss was 3.1 million dollars, or 0.28 dollars per diluted share. Cash, cash equivalents and investment securities totaled 169.8 million dollars with no debt. CEO Nick Johnson said revenue remained sequentially stable, supported by coach productivity and positive coach leading indicators as the company works through a turnaround.

The results followed the July 17 announcement that OPTAVIA is being rebranded as Trilivy, a metabolic health system.

Optavia Parent Rebrands Lifestyle Brand as Trilivy Metabolic Health System

Press Release | 7/17/2026

BALTIMORE, Md. -- July 17, 2026

Medifast said it is rebranding OPTAVIA, its lifestyle brand and wholly owned subsidiary, as Trilivy, describing the new identity as a science-backed metabolic health system.

The company said Trilivy is organized as a three-phase approach labeled Reset, Refine and Renew, combining meal plans and products, one-to-one coaching, community support and habit-building tools. The launch includes Trilivy Reset Fuelings with MetaVantage Technology that the company said is intended to support fat metabolism and insulin function, with additional Fuelings planned for August.

Medifast disclosed the change in a Form 8-K and said the move marks a new era for the brand as it positions metabolic health at the center of its coaching and product offering. Optavia remains the company name used for Npros catalog purposes.

Medifast Appoints Nicholas Johnson CEO Effective June 1 as Dan Chard Becomes Chairman

Press Release | 5/26/2026

BALTIMORE, Md. -- May 26, 2026

Medifast said its board has appointed President Nicholas Johnson as chief executive officer effective June 1, 2026, completing the succession plan announced in January when Dan Chard said he would move to non-executive chairman.

Johnson's offer letter sets annual base salary at 600,000 dollars, a target bonus of 100% of base salary and a long-term incentive target of 250% of base salary. He joined Medifast in 2018 as Optavia USA market president, later led coach and client experience and field operations, and became company president in early 2026. Chard's shift to non-executive chairman is not due to any disagreement with management or the board, the company said.

Optavia is Medifast's coach-led weight-management brand.

Medifast First Quarter Revenue Falls 34% to 76 Million Dollars

Press Release | 5/4/2026

BALTIMORE, Md. -- May 4, 2026

Medifast, the parent of Optavia, reported first-quarter 2026 revenue of 76.0 million dollars, down 34.3% from 115.7 million dollars a year earlier, as the number of independent active earning coaches fell.

Active earning coaches declined 44.9% to 14,000, while revenue per active earning coach was 5,432 dollars. The company posted a net loss of 2.1 million dollars, or 0.19 dollars per diluted share, compared with a net loss of 0.8 million dollars, or 0.07 dollars per share, a year earlier. Cash, cash equivalents and investments totaled about 169 million dollars at quarter end. Management said coach productivity rose year over year for a second consecutive quarter and pointed to coach leadership advancement and field engagement as leading indicators.

Medifast said it remains focused on the coach-led Optavia model while preparing for the June 1 leadership transition in which Nicholas Johnson succeeds Dan Chard as chief executive.

Medifast Adds Two Steamboat Capital Nominees to Board Slate in Cooperation Agreement

Press Release | 3/20/2026

BALTIMORE, Md. -- March 20, 2026

Medifast, the parent of Optavia, said its board has agreed to nominate Parsa Kiai and Jeff Rose of Steamboat Capital Partners as independent director candidates at its 2026 annual meeting, provisionally scheduled for May 19, 2026, under a cooperation agreement with the investment firm, which owns more than 5 percent of Medifast's shares. Directors Jeffrey Brown and Michael Hoer will not stand for reelection.

Under the agreement, Steamboat and certain affiliates agreed to customary standstill and voting provisions through the company's 2027 annual meeting. Chairman and Chief Executive Dan Chard will still step down as CEO on June 1, 2026, and remain chairman, with President Nicholas Johnson expected to succeed him. Kiai is Steamboat's managing partner and chief investment officer, and Rose is its chief operating officer and chief financial officer.

"Our team remains focused on returning the company to profitability, growing our business and independent coach network, and maintaining a rigorous commitment to scientific innovation in this space," Chard said. Kiai said Steamboat believes "the market is significantly undervaluing the company's substantial financial and intrinsic assets as well as its long-term potential."

Optavia Parent Fourth Quarter Revenue Falls 11 Percent to 337.2 Million

Press Release | 2/21/2023

BALTIMORE, February 21, 2023 -- Medifast, Inc., parent of OPTAVIA, reported fourth-quarter 2022 revenue of 337.2 million dollars, down 10.7 percent from 377.8 million dollars a year earlier. Independent active earning OPTAVIA Coaches rose 1.8 percent to 60,900, while revenue per active earning coach fell 12.4 percent to 5,538 dollars. GAAP net income was 26.5 million dollars, or 2.41 dollars per diluted share; non-GAAP adjusted net income was 40.6 million dollars, or 3.70 dollars.

Full-year revenue rose 4.8 percent to 1.6 billion dollars, with GAAP net income of 143.6 million dollars, or 12.73 dollars per diluted share. The company ended the year with 87.7 million dollars in cash and investment securities and no interest-bearing debt.

Chairman and chief executive Dan Chard said customer retention had returned to normal levels and focus was shifting to coach growth and productivity. First-quarter 2023 guidance is revenue of 300 million to 320 million dollars and diluted EPS of 1.75 to 2.40 dollars.

Optavia Parent Third Quarter Revenue Falls 6 Percent; Cuts Full-Year Outlook

Press Release | 11/3/2022

Medifast, parent of the OPTAVIA coach-based weight management brand, reported third-quarter 2022 revenue of 390.4 million dollars, down 5.6 percent from a year earlier. Net income was 36.2 million dollars, or 3.27 dollars per diluted share, compared with 3.56 dollars, and adjusted EPS was 3.32 dollars. Gross margin was 72.5 percent.

Active earning OPTAVIA coaches rose 8.5 percent to 66,200, but average revenue per active earning coach fell 12.9 percent to 5,897 dollars as customer acquisition slowed. The company held 69.7 million dollars in cash with no debt after completing a 100 million dollar accelerated share repurchase.

Medifast cut its full-year outlook to revenue of 1.51 billion to 1.59 billion dollars from 1.58 billion to 1.66 billion dollars, and EPS of 11.61 to 13.05 dollars from 12.70 to 14.10 dollars. Chairman and chief executive Dan Chard said economic disruption was weighing on consumer spending and customer acquisition, which would affect coach productivity in the fourth quarter.

Optavia Parent Second Quarter Revenue Rises 15 Percent; Cuts Full-Year Outlook

Press Release | 8/3/2022

Medifast, the parent of OPTAVIA, said second-quarter 2022 revenue rose 15.0 percent to 453.3 million dollars. Net income was 39.1 million dollars, or 3.42 dollars per diluted share. Adjusted net income was 44.3 million dollars, or 3.87 dollars per diluted share. Active earning OPTAVIA Coaches rose 14.9 percent to 68,000, and revenue per active earning coach was 6,667 dollars.

Chairman and chief executive Dan Chard said inflation and weaker customer retention would slow second-half growth. Full-year 2022 guidance was cut to revenue of 1.58 billion to 1.66 billion dollars from 1.78 billion to 1.84 billion dollars, and non-GAAP diluted EPS of 12.70 to 14.10 dollars from 14.60 to 16.05 dollars. The company had begun a 100 million dollar accelerated share repurchase and held 61.1 million dollars in cash and investments with 27.0 million dollars of debt at June 30.

Optavia Parent First Quarter Revenue Rises 22.6 Percent to 417.6 Million

Press Release | 5/2/2022

Medifast, the parent of OPTAVIA, said first-quarter 2022 revenue rose 22.6 percent to 417.6 million dollars. Net income was 41.8 million dollars, or 3.59 dollars per diluted share. Active earning OPTAVIA Coaches rose 21.7 percent to 63,900, and revenue per active earning coach rose 1.3 percent to 6,536 dollars.

Chairman and chief executive Dan Chard said coach growth and digital engagement supported demand. The company raised full-year 2022 guidance to revenue of 1.78 billion to 1.84 billion dollars and earnings per diluted share of 14.60 to 16.05 dollars. Cash, cash equivalents, and investment securities were 122.1 million dollars at March 31, with no interest-bearing debt.

Optavia Parent Fourth Quarter Revenue Rises 42.6 Percent to 377.8 Million

Press Release | 2/23/2022

Medifast, the parent of Optavia, said fourth-quarter 2021 revenue rose 42.6 percent to 377.8 million dollars. Active earning Optavia coaches rose 35.3 percent to 59,800, and average revenue per active earning coach rose 6.6 percent to 6,321 dollars. Full-year revenue rose 63.2 percent to 1.526 billion dollars, and net income rose 59.5 percent to 164.0 million dollars, or 13.89 dollars per diluted share.

The company guided full-year 2022 revenue to 1.72 billion to 1.79 billion dollars and diluted earnings per share to 14.50 to 16.00 dollars, assuming a tax rate of about 24.25 percent to 25.25 percent. Growth was attributed to higher coach count and coach productivity in the Optavia community.

Optavia Parent Third Quarter Revenue Rises 52.3 Percent to 413.4 Million

Press Release | 11/4/2021

Medifast, the parent of Optavia, reported third quarter revenue of 413.4 million dollars, up 52.3 percent from 271.5 million dollars. Active earning Optavia coaches rose 44.9 percent to a record 61,000. Revenue per active earning coach rose 7 percent to 6,773 dollars. Net income rose 21.9 percent to 42.0 million dollars. Diluted earnings per share rose 22.3 percent to 3.56 dollars.

Chairman and chief executive Dan Chard said coaches were supporting more clients than before and that demand for the clinical plans remained high in the United States and Asia Pacific. Gross profit rose 50.5 percent to 307.1 million dollars.

The company forecast full-year 2021 revenue of 1.51 billion to 1.53 billion dollars and earnings per share of 13.27 to 13.96 dollars. During the quarter it spent 26.3 million dollars on share repurchases. A dividend of 1.42 dollars a share, declared September 9, was scheduled to be paid November 8. Cash, equivalents, and investment securities were 159.9 million dollars.

Optavia Coaches Reach a Record 59200 as Quarterly Revenue Jumps 79.2 Percent

Press Release | 8/4/2021

Medifast, the parent of Optavia, reported second-quarter revenue of 394.2 million dollars, up 79.2 percent from 220.0 million dollars. Net income rose 114.1 percent to 47.0 million dollars. Diluted earnings were 3.96 dollars a share, up 112.9 percent. Active earning Optavia coaches rose 62.2 percent to a record 59,200, and average revenue per coach rose 13.9 percent to 6,662 dollars.

Chairman and chief executive Dan Chard said the quarter was driven by more coaches and higher productivity, supported by digital tools. Optavia-branded products were 94.1 percent of consumable units sold, up from 83.0 percent a year earlier. The company said it had completed the sunset of the Medifast-branded product line. Income from operations rose 33.3 million dollars to 61.4 million dollars. Gross margin was 74.5 percent, up from 72.4 percent.

Full-year 2021 revenue guidance was 1.425 billion to 1.525 billion dollars, and earnings guidance was 12.70 to 14.17 dollars a share, assuming a tax rate of 23.25 percent to 24.25 percent. Chard said supply-chain work was aimed at supporting 2 billion dollars of revenue sooner than previously planned.

Optavia Coaches Hit a Record 52500 as Quarterly Revenue Jumps 90.9 Percent

Press Release | 5/4/2021

Medifast, the parent of Optavia, reported first-quarter revenue of 340.7 million dollars, up 90.9 percent from a year earlier. Net income rose 122.2 percent to 41.1 million dollars, or 3.46 dollars a share. Active earning Optavia coaches rose 61.0 percent to a record 52,500, and average revenue per coach rose 21.0 percent to 6,454 dollars.

Chairman and chief executive Dan Chard said coaches used company apps, social channels, and field training to support clients and new coaches. Optavia-branded products were 88.9 percent of consumable units sold, up from 79.0 percent a year earlier. The company said it planned to sunset the Medifast-branded product line by the end of the second quarter of 2021.

Income from operations rose to 52.8 million dollars. Cash, cash equivalents, and investment securities totaled 212.9 million dollars with no interest-bearing debt. The board raised the quarterly dividend about 26 percent to 1.42 dollars a share. Full-year 2021 revenue guidance was 1.4 billion to 1.475 billion dollars.

Optavia Coaches Reach a Record 44200 as Quarterly Revenue Jumps 55 Percent

Press Release | 2/25/2021

Medifast, the public company behind Optavia, reported fourth-quarter 2020 revenue of 264.9 million dollars, up 55.3 percent from a year earlier. Active earning Optavia coaches rose 39.0 percent to a record 44,200. Revenue per active earning coach rose 13.4 percent to 5,932 dollars. Net income rose 40.8 percent to 28.0 million dollars, or 2.36 dollars a diluted share.

Optavia-branded products were 87.2 percent of consumable units sold in the quarter, compared with 79.0 percent a year earlier. Gross margin was 75.2 percent. Income from operations rose to 38.0 million dollars, or 14.3 percent of revenue.

Full-year revenue rose 31.0 percent to 934.8 million dollars. Full-year net income rose 32.0 percent to 102.9 million dollars, or 8.68 dollars a share. Adjusted net income was 108.3 million dollars. Cash, cash equivalents, and investment securities totaled 174.5 million dollars, and the company had no interest-bearing debt.

Chairman and chief executive Dan Chard said coaches attracted and kept a record number of new clients and that demand for health and wellness held up through the pandemic. A quarterly dividend of 1.13 dollars a share, totaling 13.4 million dollars, was paid on February 5, 2021.